Olanzapine

*Olanzapinum*

For medical students2 min readUpdated 2026-10-10

Olanzapine is an atypical antipsychotic with a broad polyvalent profile. The drug exhibits a pronounced ability to interact with various receptor groups and demonstrates high efficacy in the treatment of psychiatric disorders.

Receptor ProfileBlocks serotonin, dopamine, adrenergic, cholinergic, and histamine receptors.

Positive SymptomsEfficacy is comparable to classic antipsychotics (such as haloperidol).

Negative SymptomsSignificantly outperforms haloperidol and risperidone in alleviating negative symptoms.

HematotoxicityHas a lesser impact on blood cell counts compared to clozapine.

Receptor Profile and Polyvalent Action

The pharmacological effect of olanzapine is due to its ability to block a wide spectrum of receptors in the central nervous system. The drug interacts with the following structures:

Serotonin receptors (5-HT₂A).
Dopamine receptors (D₁, D₂, D₃, D₄).
Adrenergic structures (α₁-adrenoceptors).
Cholinergic receptors (muscarinic acetylcholine receptors).
Histamine receptors (H₁).

This complex profile determines the clinical features of the drug and its spectrum of pharmacological effects.

Comparison with Haloperidol

The evaluation of olanzapine is often based on comparisons with classical (typical) antipsychotics, such as haloperidol.

Positive symptoms: In terms of controlling productive (positive) symptoms, olanzapine is fully comparable to haloperidol.
Negative symptoms: Regarding the alleviation of deficit (negative) symptoms, olanzapine significantly outperforms haloperidol.

Comparison with Risperidone

When choosing therapy, clinicians consider the differences between atypical antipsychotics.

Comparative analysis shows that olanzapine surpasses risperidone in resolving the negative symptoms of schizophrenia. This makes it a drug of choice in cases where deficit symptoms and patient social adaptation are prominent.

Safety Profile and Side Effects

The safety of olanzapine is evaluated based on several key parameters:

Extrapyramidal symptoms (EPS): Highly dose-dependent. At a dose of 17.5 mg/kg, extrapyramidal symptoms are minimal, but the risk increases with further dose escalation.
Hematologic effects (hematotoxicity): Unlike clozapine, olanzapine exerts a significantly lower suppressive effect on the hematopoietic system, simplifying laboratory monitoring.

Mnemonic

O-L-A-N-Z: Outperforms typicals in Negative symptoms, Antagonizes Multiple Receptors (serotonin, dopamine, adrenergic, histamine, muscarinic), and Zenith profile compared to clozapine for blood safety.

Frequently asked questions

What metabolic side effects does olanzapine cause?

As an atypical antipsychotic, olanzapine has a pronounced effect on metabolism. The main metabolic side effects include:

Weight gain — pathological increase in body mass.
Metabolic syndrome — a constellation of metabolic abnormalities.
Decreased glucose tolerance — impaired carbohydrate metabolism that increases the risk of developing type 2 diabetes mellitus.

What are the main indications for prescribing olanzapine?

The primary indications for olanzapine include various psychotic states, agitation, and hyperkinesia. The drug is used in the following cases:

Schizophrenia — to control the progression of the disease and treat acute episodes.
Psychomotor agitation — to manage agitation, confusion, and provide emergency sedation in psychoses.
Insomnia — to treat sleep disturbances in psychotic patients.
Epileptic psychoses — to manage acute episodes.
Huntington's chorea — to reduce hyperkinesia and psychotic symptoms.

What are the absolute contraindications to olanzapine use?

General contraindications for antipsychotics include severe hypotension, heart failure, and severe hepatic impairment. In patients with organic mental disorders, olanzapine is contraindicated for treating insomnia and acute psychoses because its strong anticholinergic activity can sharply decrease blood pressure and disrupt intracardiac conduction.

What is the main difference between olanzapine and haloperidol in treating negative symptoms?

Olanzapine is significantly more effective than haloperidol in managing negative symptoms, while matching its efficacy in controlling positive symptoms.

Are extrapyramidal symptoms dependent on the dose of olanzapine?

Yes, extrapyramidal adverse effects are dose-dependent: at a dose of 17.5 mg/kg they are minimal, but the risk increases with dose escalation.

Why is olanzapine safer than clozapine in terms of hematotoxicity?

Unlike clozapine, olanzapine has a much lower impact on blood cell counts and the bone marrow system.

Go deeper

Role of 5-HT₂A and D₂ receptor blockade in the therapeutic action of olanzapine
Clinical significance of muscarinic and H₁ receptor antagonism
Comparison of the safety profiles of olanzapine and clozapine
Dose-dependency of extrapyramidal symptoms in atypical antipsychotic therapy
Advantages of olanzapine over risperidone in managing negative symptoms